SCHEMBL10278366

SCHEMBL10278366

Fc1cc(CNCl)ccc1N1CC2CCC(C1)O2

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FPR1 P21462 1/20 0.35
FPR2 P25090 1/20 0.35
ALDH1A1 P00352 2/20 0.32
KDM4E B2RXH2 2/20 0.32
LMNA P02545 1/20 0.32
MAPT P10636 1/20 0.32
KLKB1 P03952 1/20 0.32
PLA2G7 Q13093 1/20 0.31
MGLL Q99685 1/20 0.31
ABHD6 Q9BV23 1/20 0.31
USP30 Q70CQ3 1/20 0.31
GAA P10253 1/20 0.31
HPGD P15428 1/20 0.31
SMN1; SMN2 Q16637 1/20 0.31
MAOB P27338 1/20 0.31
CCNT1 O60563 1/20 0.30
CCNA2 P20248 1/20 0.30
CDK2 P24941 1/20 0.30
CCND3 P30281 1/20 0.30
CDK7 P50613 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10278280 0.84 KDM4E (0.47) ALDH1A1KDM4ELMNAMAPTUSP30
Hydrochloric Acid SCHEMBL249596 0.81 SLC6A2 (0.33) FPR1FPR2KDM4EKLKB1PLA2G7
SCHEMBL21588366 0.74 CCR1 (0.36) FPR1FPR2ALDH1A1KDM4EMAPT
SCHEMBL18396772 0.74 ALDH1A1 (0.49) FPR1FPR2ALDH1A1KDM4ELMNA
SCHEMBL29390773 0.74 ALDH1A1 (0.49) FPR1FPR2ALDH1A1KDM4ELMNA
SCHEMBL10278554 0.72 PDE3B (0.41) ALDH1A1KDM4EMAPTHPGDSMN1; SMN2
SCHEMBL14845780 0.71 HTR1A (0.39) ALDH1A1MAPTGAAHPGDSMN1; SMN2
SCHEMBL10278481 0.71 LGMN (0.39) ALDH1A1LMNAMAPTGAAHPGD
SCHEMBL250260 0.70 DPP4 (0.42) ALDH1A1USP30SMN1; SMN2
SCHEMBL10232957 0.70 FPR1 (0.33) FPR1FPR2KDM4EUSP30HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8415333-B2 Bronchodilating diazaheteroaryls RESPIRATORIOUS AB (SE) 2013-04-09 US disclosed
US-20120040942-A1 NOVEL BRONCHODILATING DIAZAHETEROARYLS RESPIRATORIUS AB (SE) 2012-02-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120040942-A1 NOVEL BRONCHODILATING DIAZAHETEROARYLS CHRM3, ADRB1, ADRB3 FPR1 142/4885FPR2 250/4885ALDH1A1 468/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.